search
Back to results

Evaluation of an Ultraportable ECG Recording Device and Its Visualization Software for the Detection of Atrial Fibrillation (WITCARD)

Primary Purpose

Cardiovascular Illnesses

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
the use of the WitCard
the use of WitDisplayer
Sponsored by
Assistance Publique Hopitaux De Marseille
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Cardiovascular Illnesses

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

Patient, male or female, over 18 years of age, presenting to the cardiology-rhythmology department (consultations and hospitalizations) or to the emergency department of the Timone 2 Hospital for the management of suspicion of disorder heart rate in front of:

  • Palpitations
  • Dyspnoea, acute pulmonary edema, non-ischemic heart failure
  • Malaise, lipothymia, syncope

Exclusion Criteria:

  • Patients with clinical criteria that do not warrant the use of WitCard:
  • Immediate vital risk whatever its nature
  • Rhythmic urgency requiring treatment without delay: respiratory, circulatory or neurological distress
  • Acute Coronary Syndrome
  • Pregnant women
  • Non-beneficiaries of a social security scheme
  • Persons deprived of their liberty
  • Patient participating in another study
  • Patient in a period of exclusion determined by a previous study
  • Patient under the protection of justice, under guardianship or under guardianship

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Experimental

    Arm Label

    witcard

    Arm Description

    Outcomes

    Primary Outcome Measures

    the ratio between the number of ECGWs that allowed a physician to make a rhythmic diagnosis (ECGW interpretable) and the total number of ECGWs recorded and visualized.

    Secondary Outcome Measures

    Full Information

    First Posted
    May 28, 2019
    Last Updated
    June 3, 2019
    Sponsor
    Assistance Publique Hopitaux De Marseille
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03975725
    Brief Title
    Evaluation of an Ultraportable ECG Recording Device and Its Visualization Software for the Detection of Atrial Fibrillation
    Acronym
    WITCARD
    Official Title
    Evaluation of an Ultraportable ECG Recording Device and Its Visualization Software for the Detection of Atrial Fibrillation
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    June 2019
    Overall Recruitment Status
    Unknown status
    Study Start Date
    September 2019 (Anticipated)
    Primary Completion Date
    September 2022 (Anticipated)
    Study Completion Date
    March 2023 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Assistance Publique Hopitaux De Marseille

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The purpose is to demonstrate the usefulness of WitCard and WitDisplayer in the diagnosis of AF but more generally in the qualification of the heart rhythm and the diagnosis of cardiac arrhythmias. The main objective is therefore to demonstrate that at least 90 +/- 0.03% of ECGWs are interpretable by a physician and the primary endpoint will therefore be the ratio of the number of ECGWs that allowed a physician to make a diagnosis. rhythmic (ECGW interpretable) and the total number of ECGW recorded and viewed. The clinical trial as part of the CE medical device certification process for secondary objectives and ancillary studies will be required to assess the diagnostic performance of the WitCard + WitDisplayer system, the quality of the ECGW recorded by the WitCard, the the safety of using the WitCard, the technical performance of the WitCard ECG recorder, the ergonomics of the WitCard, and finally the performance of automatic cardiac rhythm classification algorithms.
    Detailed Description
    Monocentric, prospective, interventional study

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Cardiovascular Illnesses

    7. Study Design

    Primary Purpose
    Other
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Masking
    None (Open Label)
    Allocation
    N/A
    Enrollment
    400 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    witcard
    Arm Type
    Experimental
    Intervention Type
    Device
    Intervention Name(s)
    the use of the WitCard
    Intervention Description
    electrocardiogram (ECG)
    Intervention Type
    Other
    Intervention Name(s)
    the use of WitDisplayer
    Intervention Description
    a software to visualize, measure, annotate, comment, archive, and share the different ECGs acquired with the WitCard (ECGW) of different patients.
    Primary Outcome Measure Information:
    Title
    the ratio between the number of ECGWs that allowed a physician to make a rhythmic diagnosis (ECGW interpretable) and the total number of ECGWs recorded and visualized.
    Time Frame
    9 months

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Patient, male or female, over 18 years of age, presenting to the cardiology-rhythmology department (consultations and hospitalizations) or to the emergency department of the Timone 2 Hospital for the management of suspicion of disorder heart rate in front of: Palpitations Dyspnoea, acute pulmonary edema, non-ischemic heart failure Malaise, lipothymia, syncope Exclusion Criteria: Patients with clinical criteria that do not warrant the use of WitCard: Immediate vital risk whatever its nature Rhythmic urgency requiring treatment without delay: respiratory, circulatory or neurological distress Acute Coronary Syndrome Pregnant women Non-beneficiaries of a social security scheme Persons deprived of their liberty Patient participating in another study Patient in a period of exclusion determined by a previous study Patient under the protection of justice, under guardianship or under guardianship
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    jean-claude deharo
    Phone
    04 91 69 89 24
    Email
    JeanClaude.DEHARO@ap-hm.fr
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    jean-olivier ARNAUD
    Organizational Affiliation
    Assistance Publique Hopitaux De Marseille
    Official's Role
    Study Director

    12. IPD Sharing Statement

    Learn more about this trial

    Evaluation of an Ultraportable ECG Recording Device and Its Visualization Software for the Detection of Atrial Fibrillation

    We'll reach out to this number within 24 hrs